IHAM
PRAX icon

Integral Health Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Integral Health Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.9M Hold
40,000
– – 0.62% 43
2025
Q4 		$11.8M Buy
+40,000
New +$7.45M 0.59% 55

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Integral Health Asset Management's PRAX Position: Q1 2026 in Review

Integral Health Asset Management held its Praxis Precision Medicines (PRAX) position steady in Q1 2026 at 40,000 shares worth $12.9M. The position accounts for 0.62% of the portfolio, ranked #43.

Integral Health Asset Management first reported a position in PRAX in Q4 2025 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Integral Health Asset Management held 40,000 shares of Praxis Precision Medicines worth $12.9M as of Q1 2026.
  • Integral Health Asset Management left its Praxis Precision Medicines share count unchanged in Q1 2026.
  • Praxis Precision Medicines made up 0.62% of Integral Health Asset Management's portfolio in Q1 2026, its #43 holding.
  • Integral Health Asset Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.